Ofatumumab Biosimilar - Research Grade,ichor.bio,ICH4027
Detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ofatumumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB263050440
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameOfatumumab Biosimilar - Research Grade
Cat. No.ICH4027
Accession NumberP11836
HostHumanized
IsotypeHuman IgG1 Kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetCD20
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Ofatumumab biosimilar is an IgG1_ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody is produced in a recombinant CHO cell line using standard mammalian cell cultivation and purification technologies.
Synonyms
MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.